Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An integrated multi-omics analysis identifies protein biomarkers and potential drug targets for psoriatic arthritis

14 Feb 2025

Abstract excerpt

Psoriatic arthritis (PsA) is a complex, chronic immune-mediated inflammatory arthropathy that currently lacks definitive biomarkers and treatment targets. Identifying biomarkers and treatment targets is urgently needed for effectively managing PsA. Here, we conducted a multi-omics approach to identify protein biomarkers and potential drug targets for psoriatic arthritis. Proteome-wide Mendelian randomization (MR)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune and Inflammatory Disorders Research
Share to Psoriasis: Treatment and Pathogenesis
Share to Spondyloarthritis Studies and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39953266
DOI: 10.1038/s42003-025-07698-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An integrated multi-omics analysis identifies protein biomarkers and potential drug targets for psoriatic arthritisPMID 39953266Read ↗

Integrated multi-omics strategies for identifying novel therapies in psoriasis.Semantic proximity Read ↗

Identifying novel risk targets in inflammatory skin diseases by comprehensive proteome-wide Mendelian randomization studySemantic proximity Read ↗

Integrative Analysis of Plasma Proteomics and Transcriptomics Reveals Potential Therapeutic Targets for PsoriasisSemantic proximity Read ↗

Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study.Semantic proximity Read ↗

Mendelian randomization for autoimmune diseases: exploring causal links and drug targets in plasma proteomeSemantic proximity Read ↗

Large-scale Analyses of Disease Biomarkers and Apremilast Pharmacodynamic EffectsSemantic proximity Read ↗

Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitisSemantic proximity Read ↗

Exploring novel drug targets for atopic dermatitis through plasma proteome with genome.Semantic proximity Read ↗

Combining Clinical, Genetic and Protein Markers Using Machine Learning Models Discriminates Psoriatic Arthritis Patients From Those With PsoriasisSemantic proximity Read ↗

Clinical, genetic and omics-based biomarkers that might support the identification of the development of psoriatic arthritis in individuals with psoriasis: a narrative review of the literature.Semantic proximity Read ↗

Insights into the pathogenesis of psoriatic arthritis from genetic studies.Semantic proximity Read ↗

Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.